Browse > Article

The Effect of Two Terpenoids, Ursolic Acid and Oleanolic Acid on Epidermal Permeability Barrier and Simultaneously on Dermal Functions  

Suk Won, Lim (R&D Center of Skin Science & Cosmetics, Enprani Co.,)
Sung Won, Jung (R&D Center of Skin Science & Cosmetics, Enprani Co.,)
Sung Ku, Ahn (Department of Dermatology, College of Medicine, Yonsei University)
Bora, Kim (R&D Center of Skin Science & Cosmetics, Enprani Co.,)
In Young, Kim (R&D Center of Skin Science & Cosmetics, Enprani Co.,)
Hee Chang , Ryoo (R&D Center of Skin Science & Cosmetics, Enprani Co.,)
Seung Hun, Lee (Department of Dermatology, College of Medicine, Yonsei University)
Publication Information
Journal of the Society of Cosmetic Scientists of Korea / v.30, no.2, 2004 , pp. 263-278 More about this Journal
Abstract
Ursolic acid (UA) and Oleanolic acid (ONA), known as urson, micromerol and malol, are pentacyclic triterpenoid compounds which naturally occur in a large number of vegetarian foods, medicinal herbs, and plants. They may occur in their free acid form or as aglycones for triterpenoid saponins, which are comprised of a triterpenoid aglycone, linked to one or more sugar moieties. Therefore UA and ONA are similar in pharmacological activity. Lately scientific research, which led to the identification of UA and ONA, revealed that several pharmacological effects, such as antitumor, hepato-protective, anti-inflammatory, anticarcinogenic, antimicrobial, and anti-hyperlipidemic could be attributed to UA and ONA. Here, we introduced the effect of UA and ONA on acutely barrier disrupted and normal hairless mouse skin. To evaluate the effects of UA and ONA on epidermal permeability barrier recovery, both flanks of 8-12 week-old hairless mice were topically treated with either 0.01-0.1mg/mL UA or 0.1-1mg/mL ONA after tape stripping, and TEWL (transepidermal water loss) was measured. The recovery rate increased in those UA or ONA treated groups (0.1mg/mL UA and 0.5mg/mL ONA) at 6h more than 20% compared to vehicle treated group (p < 0.05). Here, we introduced the effects of UA and ONA on acute barrier disruption and normal epidermal permeability barrier function. For verifying the effects of UA and ONA on normal epidermal barrier, hydration and TEWL were measured for 1 and 3 weeks after UA and ONA applications (2mg/mL per day). We also investigated the features of epidermis and dermis using electron microscopy (EM) and light microscopy (LM). Both samples increased hydration compared to vehicle group from 1 week without TEWL alteration (p < 0.005). EM examination using RuO4 and OsO4 fixation revealed that secretion and numbers of lamellar bodies and complete formation of lipid bilayers were most prominent (ONA=UA > vehicle). LM finding showed that thickness of stratum corneum (SC) was slightly increased and especially epidermal thickening and flattening was observed (UA > ONA > vehicle). We also observed that UA and ONA stimulate epidermal keratinocyte differentiation via PPAR Protein expression of involucrin, loricrin, and filaggrin increased at least 2 and 3 fold in HaCaT cells treated with either ONA (10${\mu}$M) or UA (10${\mu}$M) for 24 h respectively. This result suggested that the UA and ONA can improve epidermal permeability barrier function and induce the epidermal keratinocyte differentiation via PPAR Using Masson-trichrome and elastic fiber staining, we observed collagen thickening and elastic fiber elongation by UA and ONA treatments. In vitro results of collagen and elastin synthesis and elastase inhibitory activity measurements were also confirmed in vivo findings. These data suggested that the effects of UA and ONA related to not only epidermal permeability barrier functions but also dermal collagen and elastic fiber synthesis. Taken together, UA and ONA can be relevant candidates to improve epidermal and dermal functions and pertinent agents for cosmeseutical applications.
Keywords
ursolic acid; oleanolic acid; epidermal permeability barrier; dermal function; keratinocyte terminal differentiation;
Citations & Related Records
연도 인용수 순위
  • Reference
1 H. Ohigashi, H. Takamura, K. Koshimizu, H. Tokuda, and Y. Ito, Search for possible antitumor promoters by inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus activation;ursolic acid and oleanolic acid from an anti-inflammatory Chinese medicinal plant, Glechoma hederaceae L., Cancer Lett, 30(2), 143 (1986)
2 K. Hanley, Y. Jiang, S. S. He, M. Friedman, P. M. Elias, D. D. Bikle, M. L. Williams, and K. R. Feingold, Keratinocyte differentiation is stimulated by activators of the nuclear hormone receptor peroxisome proliferator-activated receptor-$\alpha$, J. Invest. Dermatol, 110, 368 (1998)
3 G. Grubauer, K. R. Feingold, and P. M. Elias, Transepidermal water loss: the signal for recovery of barrier structure and function, J. Lipid. Res., 30, 323 (1989)
4 S. Marquina, N. Maldonado, M. L. Garduno-Ramirez, E. Aranda, M. L. Villarreal, V. Navarro, and R. Bye, Bioactive oleanolic acid saponins and other constituents from the roots of Viguiera decurrens, Phytochemistry, 56, 93 (2001)
5 H. Assefa, A. Nimrod, L. Walker, and R. Sindelar, Enantioselective synthesis and complement inhibitory assay of A/B-ring partial analogues of oleanolic acid, Bioorg. Med Chem. Lett, 11, 1619 (2001)
6 E. M. Giner-Larza, S. Manez, M. C. Recio, R. M. Giner, J. M. Prieto, M. Cerda-Nicolas, and J. L. Rios, Oleanolic acid, a 3-oxotriterpene from Pistacia, inhibits leukotriene synthesis and has anti-inflammatory activity, Eur. J. Pharmacol., 428, 137 (2001)
7 S. Y. Ryu, M. H. Oak, S. K. Yoon, D. I. Cho, G. S. Yoo, T. S. Kim, and K. M. Kim, Anti-allergic and anti-inflammatory triterpenes from the herb of Prunella vulgaris, Planta Med, 66, 358 (2000)
8 C. Martin-Cordero, M. Reyes, M. J. Ayuso, and M. Y. Toro, Cytotoxic triterpenoids from Erica andevalensis, Z Naturforsch [C], 56, 45 (2001)
9 H. H. Ko, M. H. Yen, R. R. Wu, S. J. Won, and C. B. Lin, Cytotoxic isoprenylated flavans of Broussonetia kazinoki, J. Nat. Prod., 62, 164 (1999)
10 L. Landmann, Epidermal permeability barrier: transformation of lamella-granule disks into intercellular sheets by membrane-fusion process, a freeze-fracture study, J. Invest. Dermatol., 87, 202 (1986)   DOI   ScienceOn
11 H. Matsuura, H. Adachi, R. C. Smart, X. Xu, J. Arata, and A. M. Jetten, Correlation between expression of peroxisome proliferator-activated receptor $\beta$ and tracheobronchial epithelial cells, Mol. Cell. Endocrinol., 147, 85 (1999)   DOI   ScienceOn
12 S. A. Kliwer, K. Umesono, D. J. Noonan, R. A. Heyman, and R. M. Evans, Convergence of 9-cisretinoid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors, Nature, 358, 771 (1992)
13 H. E. Xu, M. H. Lambert, V. G. Montana, K. D. Plunket, L. B. Moore, J. L. Collins, J. A. Oplinger, S. A. Kliewer, R. T. Jr Gampe, D. D. Mckee, J. T. Moore, and T. M. Willson, Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors, Proc. Natl. Acad. Sci. USA., 94, 4318 (1997)
14 M. Gottlicher, E. Widmark, Q. Li, and J. A. Gustafsson, Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor, Proc. Natl. Acad. Sci. USA, 15, 89, 4653 (1992)
15 Y. Nishimori, H. Tsuruoka, and K. Matsumoto, A new approach for the improvement of photoaged skin through collagen fiber bundle reconstruction mechanism, In: Proceedings of the 20th International Federation of Societies of Cosmetic. Chemists: Congress, Section O009, 1
16 G. J. Gendimenico, and J. A. Mezick, Pharmacological effects of retinoids on skin cells, Skin Pharmacol., 6, 24 (1993)
17 M. Gottlicher, A. Demoz, D. Svensson, P. Tollet, R. K. Berge, and J. A. Gustafsson, Structural and metabolic requirements for activators of the peroxisome proliferator-activated receptor, Biochem Pharmacol., 46, 2177 (1993)
18 M. E. Alvarez, A. O. Maria, and J. R. Saad, Diuretic activity of Fabiana patagonica in rats, Phytother Res., 16, 71 (2002)
19 N. Y. Schurer, and P. M. Elias, The biochemistry and function of stratum corneum lipids. In: Elias P (ed.) Skin Lipids, Advances in Lipid Res San Diego: Academic Press, 24, 27 (1991)
20 S. K. Ahn, S. M. Hwang, S. J. Jiang, E. H. Choi, and S. H. Lee, The changes of epidermal calcium gradient and transitional cells after prolonged occlusion following tape stripping in murine epidermis, J. Invest. Dermatol., 113, 189 (1999)
21 R. Mukherjee, J. Strasser, L. Jow, P. Hoener, J. R. Jr Paterniti, and R. A. Heyman, RXR agonists activate PPAR-inducible genes, lower triglycerides, and raise HDL levels in vivo, Arterioscler Thromb Vasc Biol, 18, 272 (1998)
22 K. Schoonjans, B. Staels, and J. Auwerx, Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression, J. Lipid. Res., 37, 907 (1996)
23 S. B. Mahto, S. K. Sarkar, and G. Poddar, phytochemistry, 7, 3037 (1988)
24 K. Yu, W. Bayona, C. B. Kallen, H. P. Harding, C. P. Ravera, G. MaMahon, M. Brown, and M. A. Lazar, Differential activation of peroxisome proliferator-activated receptors by eicosanoids, J. Biol. Chem, 270, 23975 (1995)
25 H. Q. Tang, J. Hu, L. Yang, and R. X. Tan, Terpenoids and flavonoids from Artemisia species, Planta Med, 66, 391 (2000)
26 H. Ismaili, S. Tortora, S. Sosa, S. Fkih-Tetouani, A. llidrissi, R. Della Loggia, A. Tubaro, and R. Aquino, Topical anti-inflammatory activity of Thymus willdenowii, J. Pharm. Pharmacol., 53, 1645 (2001)
27 Y. Muto, M. Ninomiya, and H. Fujiki, Present status research on cancer chemoprevention in Japan, Japanese J. Clinical Oncology, 20, 219 (1990)
28 E. Fuchs, Epidermal differentiation: the bare essentials, J. Cell. BioI., 111, 2807 (1990)
29 K. Tsukahara, S. Moriwaki, T. Fujimura, and Y. Takema, Inhibitory effect of an extract of Sangui-sorba officinalis L. on ultraviolet-B-induced photo-damage of rat skin, Biol. Pharm Bull., 24, 998 (2001)
30 P. M. Steinert, The complexity and redundancy of epithelial barrier function, J Cell Biol, 151, F5 (2000)   DOI
31 D. Both, K. Goodzova, D. B. Yarosh, and D. A. Brown, Liposome-encapsulated ursolic acid increased ceramides and collagen in human skin cells, Arch Dermatol. Res., 293, 569 (2002)
32 C. Ma, N. Nakamura, M. Hattori, H. Kakuda, J. Qiao, and H. Yu, Inhibitory effects on HIV-l protease of constituents from the wood of Xanthoceras sorbifolia, J. Nat. Prod, 63, 238 (2000)
33 M. Y. Rios, A. Gonzalez-Morales, and M. L. Villarreal, Sterols, triterpenes and biflavonoids of Viburnum jucundum and cytotoxic activity of ursolic acid, Planta. Med, 67, 683 (2001)
34 H. E. Xu, M. H. Lambert, V. G. Montana, D. J. Parks, S. G. Blanchard, P. J. Brown, D. D. Sternbach, J. M. Lehmann, G. B. Wisely, T. M. Willson, S. A. Kliewer, and M. V. Milburn, Molecular recognition of fatty acids by peroxisome proliferator-activated receptors, Mol. Cell, 3, 397 (1999)
35 C. E. M. Griffiths and J. J. Voorhees, Topical retinoic acid for photoaging: clinical response and underlying mechanisms, Skin. Pharmacol., 6, 70 (1993)
36 P. M. Elias and G. K. Menon, Structural and lipid biochemical correlates of the epidermal permeability barrier, Adv Lipid Res., 24, 1 (1991)
37 D. J. Mangelsdorf and R. M. Evans, The RXR heterodimers and orphan receptors, Cell, 83, 841 (1995)
38 J. Pinnagoda, R. A. Tupker, T. Agner, and J. Serup, Guidelines for transepidermal water loss (TEWL) measurement. A report from the Standardization Group of the European Society of Contact Dermatitis, Contact Dermatitis. 22, 164 (1990)
39 G. Imokawa, S. Akasaki, A. Kawamata, and M. Kawai, Water-retaining function in the stratum corneum and its recovery properties by synthetic pseudoceramide, J. Soc. Cosmet. Chem, 40, 273 (1989)
40 M. River, I. Safonova, P. Lebrun, C. E. Griffiths, G. Ailhaud, and S. Michel, Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of keratinocytes, J. Invest. Dermatol, 111, 1116 (1998)
41 Y. Kashiwada, T. Nagao, A. Hashimoto, Y. Ikeshiro, H. Okabe, L. M. Cosentine, and K. H. Lee, Anti-AIDS agents 38. Anti-HIV activity of 3-Oacyl ursolic acid derivatives, J. Nat. Prod, 63, 1619 (2000)
42 F. Hollosy, M. Idei, G. Csorba, E. Szabo, G. Bokonyi, A. Seprodi, G. Meszaros, B. Szende, and G. Keri, Activation of caspase-3 protease during the process of ursolic acid and its derivative-induced apoptosis, Anticancer. Res., 21, 3485 (2001)
43 S. A. Kliewer, S. S. Sundseth, and S. A. Jones et al., Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors, Proc. Natl. Acad. Sci. USA, 94, 4318 (1997)
44 C. Y. Choi, H. J. You, and H. G. Jeong, Nitric oxide and tumor necrosis factor-a production by oleanolic acid via NF-kB activation in macrophages, Biochem. Bioptiys. Res. Commun, 288, 49 (2001)
45 M. Ponec, A. Weerheim, and J. Kempenaar, Retinoids and lipid changes in keratinocytes, Methods. Enzymol., 190:30
46 M. A. Lampe, M. L. Williams, and P. M. Elias, Human epidermal lipids: characterization and modulations during differentiation, J Lipid Res., 24, 131 (1983)
47 H. Keller, C. Dreyer, J. Medin, A. Mahfoudi, K. Ozato, and W. Wahli, Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers, Proc. Natl. Acad Sci., 90, 2160 (1993)
48 H. Tokuda, H. Ohigashi, K. Koshimizu, and Y. Ito, Inhibitory effects of ursolic and oleanolic acid on skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate, Cancer Letters, 33, 279 (1986)
49 F. Hollosy, G. Meszaros, G. Bokonyi, M. Idei, A. Seprodi, B. Szende, and G. Keri, Cytotoxic and protein tyrosine kinase inhibitory activity of ursolic acid in A431 human tumor cells, Anticancer Res., 20, 4563 (2000)
50 K. Hanley, Y. Jiang, D. Crumrine, N. M. Bass, R. Appel, P. M. Elias, M. L. Williams, and K. R. Feingold, Activators of the nuclear hormone receptors PPAR $\alpha$ and FXR accelerate the development of the fetal epidermal permeability barrier, J. Clin. Invest., 100, 705 (1997)
51 D. Baricevic, S. Sosa, Della Loggia R, A. Tubaro, B. Simonovska, A. Krasna, and A. Zupancic, Topical anti-inflammatory activity of Salvia officinalis L. leaves: the relevance of ursolic acid, J. Ethnopharmacol, 75, 125 (2001)
52 A. E. K. James, D. W. Timothy, and L. Gorden, Inhibition of human leucocyte and porcine pancreatic elastase by homologues of bovine pancreatic truosin inhibitors, Biochemistry, 35, 9090 (1996)
53 F. Lauthier, L. Taillet, P. Trouillas, C. Delage, and A. Simon, Ursolic acid triggers calcium-dependent apoptosis in human Daudi cells, Anticancer Drugs, 11, 737 (2000)
54 S. Kersten, B. Desvergne, and W. Wahli, Roles of PPAR in health and disease, Nature, 405, 421 (2000)
55 L. G. Komuves, K. Hanley, M. Q. Man, P. M. Elias, M. L. Williams, and K. R. Feingold, Keratinocytes differentiation in hyperproliferative epidermis: topical application of PPAR $\alpha$ activators restores tissue homeostasis, J. Invest. Dermatol., 115, 361 (2000)
56 T. K. Yim, W. K. Wu, W. F. Pak, and K. M. Ko, Hepatoprotective action of an oleanolic acid-enriched extract of Ligustrum lucidum fruits is mediated through an enhancement on hepatic glutathione regeneration capacity in mice, Phytother. Res., 15, 589 (2001)
57 K. Hanley, L. G. Komuves, N. B. Bass, S. S. He, Y. Jiang, D. Crumrine, R. Appel, M. Friedman, J. Bettencourt, K. Min, P. M. Elias, M. L. Williams, and K. R. Feingold, Fetal epidermal differentiation and barrier development in vivo is accelerated by nuclear hormone receptor activators, J. Invest. Dermatol., 113, 788 (1999)
58 E. H. Choi, S. K. Ahn, and S. H. Lee, The changes of stratum corneum interstices and calcium distribution of follicular epithelium of experimentally induced comedones (EIC) by oleic acid, Exp Dermatol. 6, 29 (1997)
59 J. Rogers, C. Harding, A. Mayo, J. Banks, and A. Rawlings, Stratum corneum lipids: the effects of ageing and the seasons, Arch Dermatol. Res., 288, 765 (1996)
60 J. L. Bolognia, I. M. Braverman, M. E. Rousseau and P. M. Sarrel, Skin changes in menopause, Maturitas, 11, 295 (1989)
61 J Li, L. Z. Xu, and W. P. Zhu, Effects of ursolic acid and oleanolic acid on Jurkat lymphoma cell line in vitro, Zhongguo Aizheng Zazhi, 9, 395 (1999)
62 T. S. Jeong, E. I. Hwang, H. B. Lee, E. S. Lee, Y. K. Kim, B. S. Min, K. H. Bae, S. H. Bok, and S. C. Kim, Chitin synthase II inhibitory activity of ursolic acid, isolated from Crataegus pinnatifida, Planta Med, 65, 261 (1999)
63 P. G. Latha and K. R. Panikkar, Modulatory effects of ixora coccinea flower on cyclophosphamide-induced toxicity in mice, Phytother. Res; 13, 517 (1999)   DOI   ScienceOn
64 D. B. Yarosh, D. Both, and D. Brown, Liposomal ursolic acid (merotaine) increases ceramides and collagen in human skin, Horm Res, 54, 318 (2000)
65 P. W. Wertz and D. T. Downing, Epidermal lipids. In: L. A. Golsmith (ed.) Physiology, Biochemistry and Molecular Biology of the skin New York: Oxford University Press, 205 (1991)
66 M. River, I. Casiel, I. Safonova, G. Ailhaud, and S. Michel, Peroxisome proliferator activated receptorenhances lipid metabolism in a skin equivalent model, J. Invest. Dermatol, 114, 681 (2000)
67 L. G. Komuves, K. Hanley, A. M. Lefebver, M. Q. man, D. C. Ng, D. D. Bikle, M. L. Williams, P. M. Elias, J. Auwerx, and K. R. Feingold, Stimulation of PPAR $\alpha$ promotes epidermal keratinocyte differentiation in vivo, J. Invest. Dermatol., 115, 353 (2000)
68 H. G. Jeong, Inhibition of cytochrome P450 2E1 expression by oleanolic acid hepatoprotective effects against carbon tetrachloride-induced hepatic injury, Toxicol. Lett., 105, 215 (1999)
69 Y. Wang, W. W. Porter, N. Suh, T. Honda, G. W. Gribble, L. M. Lessenitzer, K. D. Plunket, D. J. Mangelsdorf, S. G. Blanchard, T. M. Willson, and M. B. Sporn, A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor g, Mol Endocrinol, 14, 1550 (2000)
70 D. T. Downing, Lipid and protein structures in the permeability barrier of mammalian epidermis, J Lipid Res., 33, 301 (1992)
71 J. Liu, Pharmacology of oleanolic acid and ursolic acid, J. Ethnopharmacol, 49, 57 (1995)
72 J. Uitto and E. F. Bernstein, Molecular mechanisms of cutaneous aging: connective tissue alterations in the dermis, J. Invest. Dermaiol., 3, 41 (1998)
73 B. Saraswat, P. K. Visen, and D. P. Agarwal, Ursolic acid isolated from Eucalyptus tereticornis protects against ethanol toxicity in isolated rat hepatocytes, Phytother. Res; 14, 163 (2000)
74 M. T. Huang, C. T. Ho, Z. Y. Wang, T. Ferraro, Y. R. Lou, K. Stauber, W. Ma, and C. Gecrgiadis, Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid, Cancer. Res., 154(3), 701 (1994)
75 K. Subbaramaiah, P. Michaluart, M. B. Sporn, and A. J. Dannenberg, Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells, Cancer Res., 60, 2399 (2000)
76 H. J. Cha, M. T. Park, H. Y. Chung, N. D. Kim, H. Sato, M. Seiki, and K. W. Kim, Ursolic acid induced down-regulation of MMP-9 gene is mediated through the nuclear translocation of glucocorticoid receptor in HT1080 human fibrosarcoma cells, Oncogene, 16, 771 (1998)